e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Airway regulation and response II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway smooth muscle-derived fractalkine needs VIP to induce mast cell chemotaxis
P. Berger, A. El-Shazly, P. O. Girodet, R. Marthan, M. Tunon de Lara (Bordeaux, France)
Source:
Annual Congress 2005 - Airway regulation and response II
Session:
Airway regulation and response II
Session type:
Thematic Poster Session
Number:
870
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Berger, A. El-Shazly, P. O. Girodet, R. Marthan, M. Tunon de Lara (Bordeaux, France). Airway smooth muscle-derived fractalkine needs VIP to induce mast cell chemotaxis. Eur Respir J 2005; 26: Suppl. 49, 870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Eotaxin/CCL11 inhibits proliferation of human airway smooth muscle cells
Source: Eur Respir J 2005; 26: Suppl. 49, 127s
Year: 2005
Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK
Source: Eur Respir J 2006; 28: Suppl. 50, 854s
Year: 2006
Human airway smooth muscle cell and mast cell interaction is mediated via CD44 and CD51 in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 712s
Year: 2005
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008
LSC Abstract – Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation in asthma
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Eosinophil subtypes’ effect on airway smooth muscle cells differentiation and migration in asthma
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020
Eotaxin and CCR3 expression in cultured human airway smooth muscle cells
Source: Eur Respir J 2002; 20: Suppl. 38, 2s
Year: 2002
MNK-1 inhibition reduces proliferation and CXCL10 in airway smooth muscle cells
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Mitogenic effects of RBL-1 cell mediators on human airway smooth muscle (ASM) cells are via nonproteolitic actions
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003
Human lung mast cells adhere to airway smooth muscle
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
IL-4/IL-13 promote Th2-type inflammatory changes in airway smooth muscle and induce myofibroblast differentiation
Source: Eur Respir J 2005; 26: Suppl. 49, 224s
Year: 2005
IgE-induced pro-inflammatory extracellular matrix composition in airway smooth muscle cells is prevented by omalizumab
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012
Tocotrienol inhibits TGF-beta1-induced human airway smooth muscle cell differentiation
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Stimulation of pulmonary smooth muscle cell proliferation by endothelial progenitor cells
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Integrins regulate eosinophil adhesion to the airway smooth muscle cells in asthma patients
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015
Cysteinyl leukotrienes augment human airway smooth muscle migration
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
Co-culture of human airway epithelial cells alter the proliferation of human airway smooth muscle cells
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002
The effect of gamma-tocotrienol on human airway smooth muscle cell proliferation and migration
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Eosinophils promote airway smooth muscle cells differentiation to the contractile phenotype in asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept